Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia

Recruiting Phase 2 Interventional Study
Aphasia Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
University of Pittsburgh · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Aphasia is a language disorder caused by stroke and other acquired brain injuries that affects over two million people in the United States and which interferes with life participation and quality of life. Anomia (i.e., word- finding difficulty) is a primary frustration for people with aphasia. Picture-based naming treatments for anomia are widely used in aphasia rehabilitation, but current treatm…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Existing diagnosis of chronic (\>6 months) aphasia subsequent to left hemisphere ischemic or hemorrhagic stroke. * Impaired performance on 2/8 sections of the Comprehensive Aphasia Test. Exclusion Criteria: * History of other acquired or progressive neurological disease. * S…
Contacts

Alyssa Kelly, M.A., CCC-SLP

412-648-3274

ank155@pitt.edu

CONTACT